Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Antimalarial drug discovery has until recently been driven by high-throughput phenotypic cellular screening, allowing millions of compounds to be assayed and delivering clinical drug candidates. In this review, we will focus on target-based approaches, describing recent advances in our understanding of druggable targets in the malaria parasite. Targeting multiple stages of the Plasmodium lifecycle, rather than just the clinically symptomatic asexual blood stage, has become a requirement for new antimalarial medicines, and we link pharmacological data clearly to the parasite stages to which it applies. Finally, we highlight the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY, a web resource developed for the malaria research community that provides open and optimized access to published data on malaria pharmacology.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/bph.16144 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Advances in Artemisinin-based Therapies: Innovations in Synthesis, Drug Delivery, and Expanding Therapeutic Applications.
Recent Pat Anticancer Drug Discov
September 2025
School of Pharmacy, Devi Ahilya Vishwavidalaya, Indore, M.P., India.
Artemisinin, a natural compound derived from Artemisia annua, has significantly impacted the treatment of malaria and has shown promise in various other therapeutic applications. This review explores the molecular structure of artemisinin and its derivatives, as well as advancements in synthetic and semi-synthetic production methods, and their broader therapeutic effects beyond malaria, including potential uses in cancer, neurological disorders, and viral infections. It also discusses contemporary drug delivery innovations, such as nanoparticles and liposomal systems, which aim to enhance the bioavailability and targeted action of artemisinin, while addressing issues of drug resistance, particularly in parasitic diseases like malaria.
View Article and Find Full Text PDFFrom pan-active to parasite-selective antiparasitic agents: A scaffold hopping approach.
Eur J Med Chem
August 2025
Department of Pharmaceutical Sciences, University of Milan, Via Mangiagalli 25, 20133, Milan, Italy.
Vector-borne parasitic diseases (VBPDs) represent a major global public health concern, with human African trypanosomiasis (HAT), Chagas disease, leishmaniasis, and malaria collectively threatening millions of people, particularly in developing regions. Climate change may further influence their transmission and geographic spread, increasing the global burden. As drug resistance continues to rise, there is an urgent need for novel therapeutic agents to expand treatment options and limit disease progression.
View Article and Find Full Text PDFEfficacy of Spatial Repellents in Malaria Prevention: A Meta-Analysis of Randomized Controlled Trials.
Am J Trop Med Hyg
September 2025
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
The efficacy of spatial repellents in preventing malaria infections is unclear. In the present study, a meta-analysis of four randomized controlled trials conducted in China, Indonesia, and Kenya, involving 6,745 participants, was conducted to assess the efficacy of spatial repellents in reducing malaria infections. The risk of malaria infection was lower with the use of spatial repellents (681 [20.
View Article and Find Full Text PDFPlasmoDocking: A User-Friendly Open-Source Web Tool for Virtual Screening Targeting Plasmodium falciparum Enzymes.
J Comput Chem
September 2025
Laboratório de Bioinformática e Química Medicinal, Fundação Oswaldo Cruz Rondônia (LABIOQUIM-Fiocruz-RO), Porto Velho, Rondônia, Brazil.
Virtual screening through molecular docking represents a fundamental computational methodology extensively employed in the identification of therapeutic compounds for malaria and other parasitic diseases. Although numerous software platforms are available, including AutodockGPU, the command-line interface requirements present significant barriers to non-specialized users, while multi-target screening protocols introduce additional complexity in receptor preparation procedures. To address these limitations, we developed Plasmodocking, a comprehensive web-based platform designed to automate molecular docking simulations against predefined Plasmodium falciparum targets (https://plasmodocking-unir.
View Article and Find Full Text PDFCadinapyridine sesquiterpene alkaloids from Artemisia annua and in vitro cytotoxicity and antiplasmodial activities.
PLoS One
September 2025
UMR 152 PharmaDev, Université de Toulouse, UPS, IRD, Toulouse, France.
Artemisia annua L. (A. annua) is a medicinal herb that has been used for the last two millennia to treat various diseases.
View Article and Find Full Text PDF